P066 The combination of rituximab and HyperCVAD in treatment of Burkitt lymphoma – a single institution expirience

Authors :: Bosko Andjelic
S. Jankovic
Milica Colovic
V. Milosevic
Biljana Mihaljevic
Ljubomir Jakovic
Milena Todorovic
A. Sretenovic
M. Mitrovic
M. Petrovic
Maja Perunicic
V. Cemerikic
Source :: Leukemia Research. 31:S94
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Hematology
medicine.disease
Lymphoma
Internal medicine
medicine
Rituximab
Single institution
business
medicine.drug

Full Text Access

Tools